Oral calcitriol (1,25-dihydroxyvitamin D3) does not augment UVB phototherapy for plaque psoriasis

J Am Acad Dermatol. 1996 Aug;35(2 Pt 1):272-4. doi: 10.1016/s0190-9622(96)90352-7.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Calcitriol / administration & dosage
  • Calcitriol / adverse effects
  • Calcitriol / therapeutic use*
  • Calcium / blood
  • Calcium / urine
  • Combined Modality Therapy
  • Double-Blind Method
  • Humans
  • Hypercalcemia / etiology
  • Placebos
  • Psoriasis / drug therapy
  • Psoriasis / radiotherapy*
  • Ultraviolet Therapy* / adverse effects

Substances

  • Placebos
  • Calcitriol
  • Calcium